May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Polynitroxyl Albumin Inhibits Sickle RBC Retention Initiated by TNF Alpha
Author Affiliations & Notes
  • S.Y. Kim
    Dept Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • I.A. Bhutto
    Dept Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • C. Mocanu
    Dept Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • C.A. Merges
    Dept Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • S. Suzuka
    Dept Hematology, Albert Einstein College of Medicine, Bronx, NY, United States
  • M. Li
    SynZyme Technologies, LLC, Irvine, CA, United States
  • C.J. Hsia
    SynZyme Technologies, LLC, Irvine, CA, United States
  • M.E. Fabry
    SynZyme Technologies, LLC, Irvine, CA, United States
  • R.L. Nagel
    SynZyme Technologies, LLC, Irvine, CA, United States
  • G.A. Lutty
    SynZyme Technologies, LLC, Irvine, CA, United States
  • Footnotes
    Commercial Relationships  S.Y. Kim, None; I.A. Bhutto, None; C. Mocanu, None; C.A. Merges, None; S. Suzuka, None; M. Li, SynZyme Technologies, LLC E; C.J. Hsia, SynZyme Technologies, LLC I, E; M.E. Fabry, None; R.L. Nagel, None; G.A. Lutty, None.
  • Footnotes
    Support  NIH grants HL45922 (GAL), HL38655 (RLN), and EY01765 (Wilmer), the Reginald F. Lewis Foundation
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4913. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.Y. Kim, I.A. Bhutto, C. Mocanu, C.A. Merges, S. Suzuka, M. Li, C.J. Hsia, M.E. Fabry, R.L. Nagel, G.A. Lutty; Polynitroxyl Albumin Inhibits Sickle RBC Retention Initiated by TNF Alpha . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4913.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Clinical trials to alleviate sickle cell painful crisis and acute lung syndrome by breathing nitric oxide (NO) are in progress. Both events in sickle cell disease are caused by sickle RBC (sRBC)-mediated occlusions. Reactive oxygen species (ROS) are formed in both events and destroy NO. This study evaluates, in a rat model of sickle RBC-mediated occlusion in retina and choroid, the therapeutic potential of polynitroxyl albumin (PNA), a multifunctional antioxidant vascular protectant. Methods:At time zero two groups of anesthetized male Sprague Dawley (SD) rats were given 20 mg tumor necrosis factor alpha (TNF)/kg IP and one group was given phosphate buffered saline (PBS) as control. For each group, the first dose of PNA or control human serum albumin (HSA) (1 ml) was administered via the penile vein at 1hr post TNF. The second dose of PNA or HSA (2 ml) was given via a femoral catheter at 4.75 hrs post TNF. Finally, fluorescent labeled reticulocyte-rich sickle RBCs were administer via a femoral catheter at 5 hrs and permitted to circulate for 5 minutes. The number of sRBCs/retina and number per mm2 of choroids were counted. Results:Administration of PNA or HSA did not affect blood pressure nor PaO2. TNF significantly increased retina retention of sRBCs receiving HSA compared to rats receiving PBS/HSA (p=0.0014). Rats receiving PNA/TNF had significantly less retained cells than those receiving HSA/TNF (p <2.3 E-5). The number of sRBCs retained in the PNA/TNF treatment group was indistinguishable to that of PBS/HSA control group. Likewise, TNF increased retention of sRBCs per mm2 of choroid (p=0.005) and PNA inhibited the TNF-mediated retention of sRBCs in choroid with the same efficacy (p=0.0025). Conclusions: Sickle RBC vaso-occlusion induced by TNF in retina and choroid in a rat model was completely inhibited by PNA. This positive outcome may be due to PNA’s ability to scavenge ROS, which destroy NO. Based on our ocular observations, we hypothesize that PNA may be also an efficacious treatment for painful crisis and acute chest syndrome, which are triggered by sRBC-mediated occlusions and inflammatory cascade

Keywords: vascular occlusion/vascular occlusive disease • antioxidants • hypoxia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×